Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation
Silvia Arifi(Goethe University Frankfurt), Daniel Merk(Ludwig-Maximilians-Universität München), Laura Isigkeit(Goethe University Frankfurt), Stefan Knapp(Goethe University Frankfurt), Jan Heering(Fraunhofer Institute for Translational Medicine and Pharmacology), Astrid Kaiser(Goethe University Frankfurt), Julian A. Marschner(Ludwig-Maximilians-Universität München), Georg Höfner(Ludwig-Maximilians-Universität München), Julius Pollinger(Goethe University Frankfurt), A. Chaikuad(Goethe University Frankfurt), Ewgenij Proschak(Goethe University Frankfurt), Lennart Obeser(Ludwig-Maximilians-Universität München), Pascal Heitel(Goethe University Frankfurt)
Cited by 49
Related Papers
Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
|Cell|2012|1.7k
The promise and peril of chemical probes
|Nature Chemical Biology|2015|848
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Bromodomains as therapeutic targets
|Expert Reviews in Molecular Medicine|2011|436
DOGS: Reaction-Driven de novo Design of Bioactive Compounds
|PLoS Computational Biology|2012|264